Published online before print May 19, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, USA;
Department of Pediatrics, Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA;
Department of Natural Science, Virginia Union University, Richmond, Virginia, USA; and
Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
2. Correspondence: Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, W1157 Biomedical Science Tower, Pittsburgh, PA 15261, USA. E-mail: joanne{at}pitt.edu
ABSTRACT
Foxp3+ T regulatory cells are required to prevent autoimmune disease, but also prevent clearance of some chronic infections. While natural T regulatory cells are produced in the thymus, TGF-β1 signaling combined with T-cell receptor signaling induces the expression of Foxp3 in CD4+ T cells in the periphery. We found that ICAM-1–/– mice have fewer T regulatory cells in the periphery than WT controls, due to a role for ICAM-1 in induction of Foxp3 expression in response to TGF-β1. Further investigation revealed a functional deficiency in the TGF-β1-induced translocation of phosphorylated Smad3 from the cytoplasmic compartment to the nucleus in ICAM-1-deficient mice. This impairment in the TGF-β1 signaling pathway is most likely responsible for the decrease in T regulatory cell induction in the absence of ICAM-1. We hypothesized that in the presence of an inflammatory response, reduced production of inducible T regulatory cells would be evident in ICAM-1–/– mice. Indeed, following Mycobacterium tuberculosis infection, ICAM-1–/– mice had a pronounced reduction in T regulatory cells in the lungs compared with control mice. Consequently, the effector T-cell response and inflammation were greater in the lungs of ICAM-1–/– mice, resulting in morbidity due to overwhelming pathology.
Key Words: tuberculosis granuloma ICAM-1 Foxp3 Treg
This article has been cited by other articles:
![]() |
P. L. Lin and J. L. Flynn Understanding Latent Tuberculosis: A Moving Target J. Immunol., July 1, 2010; 185(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||